Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gynecology
»
Breast Diseases
07. August 2026
Search
medline.ch
Breast Diseases
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Reproduction
Genital Diseases female
Infertility
Breast Diseases
Menopause
Pregnancy
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 11044
Articles 1 - 20 / 220870
Next-generation endocrine therapy in HR+/HER2 - breast cancer: oral SERDs, ER-targeting innovations, and ctDNA-driven ESR1 mutation-guided switching.
Breast Cancer
Yao N, Xu G, Duan N, Han F, Li W, Qu J.
PMID: 42565973 [PubMed - as supplied by publisher]
Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.
Cancer
Huang L, Cook LS, Tang MC, Doody DR, Peters U, Sun W, Huyghe JR, Malone KE, Li CI.
PMID: 42565301 [PubMed - indexed for MEDLINE]
Ultra-Hypofractionated Palliative Radiotherapy for Symptomatic Locoregionally Advanced Breast Cancer: A Prospective, Single-Arm Phase II Trial of Toxicity and Quality-of-Life Outcomes.
Breast Care (Basel)
Parambath HK, Gupta S, Thimmarayappa A, Kn YI, Ramdulari AV.
PMID: 42565057 [PubMed - as supplied by publisher]
Triple-Negative Breast Cancer: Predictive Factors for Pathological Complete Response and Prognostic Impact of Clinical, Pathological, and Radiological Parameters.
Breast Care (Basel)
Zenciroglu M, Abbasoglu P, Y, Topgul OH, Pekuz CK, Bas.
PMID: 42565028 [PubMed - as supplied by publisher]
Portable structured-light 3D volumetry for breast and flap assessment: Technical validation and workflow development.
JPRAS Open
Chen Y, García-Cañal Á, Xu Y, Wu F, Zapata-Negreiros JA, Cámara-Pérez J, Cuéllar IN, Cuéllar CN, Rebollo-Fernández C, Lasso JM.
PMID: 42564832 [PubMed]
SGLT2 inhibitors and risk of distant metastasis in patients with breast cancer and type 2 diabetes: a target trial emulation with biological plausibility analysis.
EClinicalMedicine
Chen PH, Chang WC, Jhou HJ, Chen HY, Huang MH, Lee CH.
PMID: 42564795 [PubMed]
Time to diagnosis and treatment and breast cancer outcomes in young women: a systematic review protocol.
MethodsX
Jacobs W, Atwood T, Gonzalez R, Lee AW.
PMID: 42564769 [PubMed]
Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis.
Front Oncol
Zhou H, Wei L, Zhou Z, Jiang G, Li S, Zeng X.
PMID: 42564113 [PubMed]
Essential oil-based interventions for chemotherapy-induced nausea and vomiting in women with breast cancer: a systematic review and meta-analysis.
Front Med (Lausanne)
Jin K, Yan S, Xu L.
PMID: 42564042 [PubMed]
Tolerance of chemotherapy in breast cancer patients in different age groups: A single-centre South African study.
S Afr Med J
Zwane AM, Oosthuizen G, Stopforth L, Joffe M, Martin L, .
PMID: 42563663 [PubMed - indexed for MEDLINE]
Clinicopathological features of pregnancy-associated breast cancer at Chris Hani Baragwanath Academic Hospital, South Africa.
S Afr Med J
Levenberg L, Kruger D, Cubash H, Murugan N.
PMID: 42563652 [PubMed - indexed for MEDLINE]
Hip Mass: Breast Carcinoma.
J Coll Physicians Surg Pak
Shabbir A, Osmani AH.
PMID: 42563353 [PubMed - indexed for MEDLINE]
Ultrasound-Guided, Indocyanine Green-Directed Robot-Assisted Breast Surgery for Benign Tumours.
J Coll Physicians Surg Pak
Liu N, Zhang G, Ren C, Cao J, Liao N.
PMID: 42563333 [PubMed - indexed for MEDLINE]
Tissue-stiffness-driven platelet activation emerges as a potential target for breast cancer prevention and treatment.
Cell Commun Signal
Heenkenda MK, Wang X, Zhong W, Abrahamsson A, Reustle N, Aili D, Lundberg P, Lindahl TL, Dabrosin C.
PMID: 42563161 [PubMed - indexed for MEDLINE]
Understanding barriers and facilitators to breast cancer screening: insights from South Asian women and general practitioners in Victoria, Australia.
Aust J Prim Health
Rizvi F, White V, Livingston PM, Bellingham K, McLachlan SA, Passey D, Philip J.
PMID: 42562622 [PubMed - indexed for MEDLINE]
(68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study.
J Nucl Med
Gao S, Zhang Z, Shi C, Cheng C, Ma X, Zhao X, Liu Y.
PMID: 42562610 [PubMed - as supplied by publisher]
Moderating Role of Perceived Neighborhood Environment on Physical Activity and BMI Outcomes of a Diet and Physical Activity Intervention Among Latina Breast Cancer Survivors.
J Phys Act Health
Hill CM, Rillamas-Sun E, Marín-Chollom AM, Ulanday KT, Koch PA, Contento IR, Ogden Gaffney A, Hershman DL, Greenlee H.
PMID: 42562369 [PubMed - as supplied by publisher]
Inflammatory breast cancer: improving research and care through the integration of preclinical evidence and technological advances.
Crit Rev Oncol Hematol
Nicolo E, Manai M, Soliman A, Reduzzi C, Cristofanilli M.
PMID: 42562246 [PubMed - as supplied by publisher]
F11 Receptor/Junctional Adhesion Molecule-A: a novel therapeutic target in breast cancer.
Biochimie
Bednarek R, .
PMID: 42562075 [PubMed - as supplied by publisher]
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
Cell Rep Med
Li JJ, Ma LX, Ji P, Chen L, Wu J, Liu GY, Hou YF, Di GH, Hu Z, Jiang YZ, Fan L, Wang ZH, Yu KD, Zhi-Ming Shao.
PMID: 42561949 [PubMed - as supplied by publisher]
Articles 1 - 20 / 220870
Page 1 of 11044
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy